Synthesis, molecular modeling and BACE-1 inhibitory study of tetrahydrobenzo[b] pyran derivatives.


Journal

Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703

Informations de publication

Date de publication:
03 2019
Historique:
received: 03 03 2018
revised: 16 11 2018
accepted: 17 11 2018
pubmed: 5 12 2018
medline: 14 1 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

β-Secretase (BACE1) has been broadly documented as one of the possible therapeutic targets for the treatment of Alzheimer's disease. In this paper, we report the synthesis and the for β-secretase (BACE-1) inhibitory activity of new series of tetrahydrobenzo [b] pyran derivatives. One-pot synthesis of tetrahydrobenzo [b] pyrans was carried out by condensing aromatic aldehyde, malononitrile and 1,3-cyclohexanedione using ionic liquid 1-butyl-3-methyl imidazolium chloride ([bmIm]Cl

Identifiants

pubmed: 30502632
pii: S0045-2068(18)30205-0
doi: 10.1016/j.bioorg.2018.11.023
pii:
doi:

Substances chimiques

Aldehydes 0
Ionic Liquids 0
Protease Inhibitors 0
Pyrans 0
Amyloid Precursor Protein Secretases EC 3.4.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

202-210

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Vijaya Bhaskar (V)

Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576104, India. Electronic address: bhaskerkv@gmail.com.

Reshma Chowdary (R)

Department of Medicinal Chemistry, BITS-Pilani Hyderabad Campus, Hyderabad 500078, India.

Sheshagiri R Dixit (SR)

Novel Drug Design and Discovery Laboratory, Department of Pharmaceutical Chemistry, SET's College of Pharmacy, Dharwad 580002, India.

Shrinivas D Joshi (SD)

Novel Drug Design and Discovery Laboratory, Department of Pharmaceutical Chemistry, SET's College of Pharmacy, Dharwad 580002, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH